Biotech Values

[oc631]

Thoughts and observations on CARM


This is a restructured company through a reverse merger one year ago this month. The last three quarters they released their earnings on the 23RD of May, August, and November respectively. Now they are a month late reporting out their fourth quarter. Why the delay? It's hard to imagine that there could be a restatement or a earnings related issue after one year. Maybe just a small cap. company wrestling with putting together their first annual 10-k filing?

Another interesting development is that ABBV reported a 6.8% stake on the 13TH of this month. To my knowledge ABBV has no outstanding business relationship with this company.

The price and volume action on the stock doesn't indicate anything is afoot but the late filing and the ABBV sake taken together is intriguing, Thoughts or comments?

https://www.sec.gov/Archives/edgar/data/1485003/000110465924033949/tm248577d1_sc13g.htm